# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HYTN Cannabis Inc. wholly owned subsidiary of HYTN Innovations Inc., (CSE:HYTN) has developed and listed for sale its all-new N...
HYTN Cannabis Inc., wholly owned subsidiary of HYTN Innovations Inc. (CSE:HYTN) has been awarded a license by Health Canada all...
Skye Bioscience, Inc. (OTCQB: SKYE) and Emerald Health Therapeutics, Inc.
HYTN Innovations Inc. (CSE:HYTN) announced that it has begun accepting orders directly from Provincial buyers.
HYTN Innovations Inc.’s (CSE:HYTN) subsidiary HYTN Cannabis Inc., has awarded a license amendment by Health Canada allowing for...
Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) announced Monday that it is getting out of the recreational and med...
Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) announced that its partner, FlowerPod LLC has launched a “first-of-...
GAINERS: Indiva (OTC:NDVAF) shares closed up 9.76% at $0.4 with an estimated market cap of $54.3M.
GAINERS: Cipher Pharms Inc (OTC:CPHRF) shares closed up 20.19% at $1.62 with an estimated market cap of $43,398,257.